EN DE
STOCK COMPARISON

Neola Medical AB vs Abbott Laboratories: Fair Value & Quality

Both stocks run through our valuation models. Here is how Neola Medical AB (NEOLA) and Abbott Laboratories (ABT) compare, as of Aug 31, 2026.

As of Aug 31, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Neola Medical AB trades at SEK 0.49 versus a fair value of SEK 0.18 (-63%), while Abbott Laboratories trades at $112 versus $74.79 (-34%).
Neola Medical AB
NEOLA.ST · SEK · Health Care
-63%
upside to fair value
overvalued
PriceSEK 0.49
Fair ValueSEK 0.18
Quality43/100
Abbott Laboratories
ABT · USD · Health Care
-34%
upside to fair value
overvalued
Price$112
Fair Value$74.79
Quality67/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Neola Medical ABAbbott Laboratories
Valuation
P/E (TTM)27.7×
0.63×P/S (TTM)3.89×
0.08×P/B3.36×
EV/EBITDA15.1×
PEG1.47×
Dividend yield2.2%
Dividend per share$2.44
Profitability
-132%Net margin14%
-127%Operating margin13%
-15%Return on equity12%
-9%Return on assets6%
Growth
33%Revenue growth (YoY)8%
2.8%Avg. growth/yr (3Y)0.5%
Avg. growth/yr (5Y)5.1%
Balance & size
Debt / equity0.19×
$6MMarket cap$175B
mixedGrowth qualityhealthy

Even match: 4 to 4 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Neola Medical ABof which business quality 43 · market factors 3 Abbott Laboratoriesof which business quality 66 · market factors 55
ProfitabilityMargins and returns on capital today
0
50
Quality GrowthAre margins and returns improving?
48
47
CashflowEarnings quality: real cash, not paper profit
39
71
Fin. StrengthBalance sheet, leverage, solvency risk
92
80
InvestmentDisciplined investing over empire-building
86
65
Low VolatilityCalm price path (market factor)
10
83
MomentumPrice trend over the last 3–12 months (market factor)
0
46
52W MomentumDistance to the 52-week high (market factor)
0
39
Net IssuanceBuybacks instead of dilution
0
84

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyNeola Medical ABPrice SEK 0.49Abbott LaboratoriesPrice $112
DCF Modelsn/a-35%below the price$73.01
Earnings-Basedn/a-74%below the price$29.42
Dividend Discountn/a-65%below the price$39.73
Multiplesn/a-37%below the price$70.72
Asset-Based+28%above the priceSEK 0.63-82%below the price$20.05
Growth DCFn/a-40%below the price$67.02
Economic Profitn/a-67%below the price$37.49
Growth Earningsn/a-38%below the price$70.25
Minimum+28%above the priceSEK 0.63-82%below the price$20.05
Maximum+28%above the priceSEK 0.63-35%below the price$73.01
Median+28%above the priceSEK 0.63-53%below the price$53.37
Geometric mean+28%above the priceSEK 0.63-59%below the price$46.36

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Neola Medical AB: 0 of 1 models see the stock below the current price.

Abbott Laboratories: 26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Neola Medical AB
Bear SEK 0.12Fair Value SEK 0.18Bull SEK 0.22
SEK 0.49 = current price (white tick)
Abbott Laboratories
Bear $51.13Fair Value $74.79Bull $94.43
$112 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Neola Medical AB · Health Care

Quality score43 · below median
Fair value upside-63% · bottom 25%

Abbott Laboratories · Health Care

Quality score67 · Top 25%
Fair value upside-34% · below median

Bottom line

As of Aug 31, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Neola Medical AB trades at SEK 0.49 versus a fair value of SEK 0.18 (-63%), while Abbott Laboratories trades at $112 versus $74.79 (-34%).

Abbott Laboratories has the higher quality score (67/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.